1. Home
  2. BPMC vs OTEX Comparison

BPMC vs OTEX Comparison

Compare BPMC & OTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • OTEX
  • Stock Information
  • Founded
  • BPMC 2008
  • OTEX 1991
  • Country
  • BPMC United States
  • OTEX Canada
  • Employees
  • BPMC N/A
  • OTEX N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • OTEX EDP Services
  • Sector
  • BPMC Health Care
  • OTEX Technology
  • Exchange
  • BPMC Nasdaq
  • OTEX Nasdaq
  • Market Cap
  • BPMC 5.8B
  • OTEX 6.6B
  • IPO Year
  • BPMC 2015
  • OTEX 1998
  • Fundamental
  • Price
  • BPMC $101.35
  • OTEX $28.31
  • Analyst Decision
  • BPMC Buy
  • OTEX Hold
  • Analyst Count
  • BPMC 18
  • OTEX 7
  • Target Price
  • BPMC $125.88
  • OTEX $30.86
  • AVG Volume (30 Days)
  • BPMC 789.4K
  • OTEX 1.2M
  • Earning Date
  • BPMC 05-01-2025
  • OTEX 07-31-2025
  • Dividend Yield
  • BPMC N/A
  • OTEX 3.71%
  • EPS Growth
  • BPMC N/A
  • OTEX 295.06
  • EPS
  • BPMC N/A
  • OTEX 2.45
  • Revenue
  • BPMC $562,121,000.00
  • OTEX $5,220,017,000.00
  • Revenue This Year
  • BPMC $44.49
  • OTEX N/A
  • Revenue Next Year
  • BPMC $33.04
  • OTEX $0.88
  • P/E Ratio
  • BPMC N/A
  • OTEX $11.57
  • Revenue Growth
  • BPMC 99.19
  • OTEX N/A
  • 52 Week Low
  • BPMC $73.04
  • OTEX $22.79
  • 52 Week High
  • BPMC $121.90
  • OTEX $34.20
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 56.34
  • OTEX 60.01
  • Support Level
  • BPMC $94.38
  • OTEX $27.70
  • Resistance Level
  • BPMC $102.52
  • OTEX $28.60
  • Average True Range (ATR)
  • BPMC 3.77
  • OTEX 0.45
  • MACD
  • BPMC -0.38
  • OTEX -0.03
  • Stochastic Oscillator
  • BPMC 79.29
  • OTEX 76.42

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About OTEX Open Text Corporation

Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: